This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, G. Articles by Mosser, D. M. Search for Related Content PubMed PubMed Citation Articles by Chen, G. Articles by Mosser, D. M.

 Previous Article  |  Next Article 

Infection and Immunity, May 2001, p. 3255-3263, Vol. 69, No. 5
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.5.3255-3263.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Vaccination against the Intracellular Pathogens Leishmania major and L. amazonensis by Directing CD40 Ligand to Macrophages

Gang Chen, Patricia A. Darrah, and David M. Mosser^*

Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland 20742

Received 17 July 2000/Returned for modification 11 August 2000/Accepted 22 February 2001

CD40 ligand (CD40L) is a potent inducer of interleukin-12 (IL-12) production from macrophages and dendritic cells. We show that combining CD40L with antigen derived from Leishmania is an effective way to preferentially induce type 1 immune responses to the antigen and to vaccinate mice against subsequent challenge with virulent organisms. Mice vaccinated in this way had smaller lesions, with more than 1,000-fold fewer parasites within them. To improve the efficiency of CD40L-induced immunopotentiation, we attempted to specifically direct CD40L to macrophages. We developed transfected cells expressing CD40L and a single Leishmania antigen, gp63. These cells bound efficiently to macrophages and induced robust IL-12 production. Vaccination with these cotransfected cells provided a significant degree of protection against challenge with virulent organisms. CD40L was also adsorbed to the surface of virulent Leishmania. These organisms induced only modest lesions in genetically susceptible mice, and the lesions had an average of 10⁵-fold fewer organisms within them relative to control mice. These studies suggest that CD40L could be exploited to improve vaccines against intracellular pathogens, especially those organisms that reside within cells expressing CD40 on their surface.

---

^* Corresponding author. Mailing address: Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742. Phone: (301) 314-2594. Fax: (301) 314-9489. E-mail: dm268{at}umail.umd.edu.

---

Infection and Immunity, May 2001, p. 3255-3263, Vol. 69, No. 5
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.5.3255-3263.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

This article has been cited by other articles:

• Field, A. E., Wagage, S., Conrad, S. M., Mosser, D. M. (2007). Reduced Pathology following Infection with Transgenic Leishmania major Expressing Murine CD40 Ligand. Infect. Immun. 75: 3140-3149 [Abstract] [Full Text]  
• VANLOUBBEECK, Y., JONES, D. E. (2004). PROTECTION OF C3HEB/FEJ MICE AGAINST LEISHMANIA AMAZONENSIS CHALLENGE AFTER PREVIOUS LEISHMANIA MAJOR INFECTION. Am J Trop Med Hyg 71: 407-411 [Abstract] [Full Text]  
• Padigel, U. M., Farrell, J. P. (2003). CD40-CD40 Ligand Costimulation Is Not Required for Initiation and Maintenance of a Th1-Type Response to Leishmania major Infection. Infect. Immun. 71: 1389-1395 [Abstract] [Full Text]  
• McDowell, M. A., Marovich, M., Lira, R., Braun, M., Sacks, D. (2002). Leishmania Priming of Human Dendritic Cells for CD40 Ligand-Induced Interleukin-12p70 Secretion Is Strain and Species Dependent. Infect. Immun. 70: 3994-4001 [Abstract] [Full Text]